Office Address

Karmanos Cancer Center
4100 John R., HW04HO
HWCRC - 4209
Detroit, 48201

Office Phone

313-576-8728

Office Fax

313-576-8767

Biography

Philip Agop Philip, MD, PhD, FRCP, serves as the Kathryn Cramer, MD, Endowed Chair in Cancer Research and is leader of the Gastrointestinal and Neuroendocrine Multidisciplinary Team at the Barbara Ann Karmanos Cancer Institute in Detroit, Michigan, United States. He also serves as professor of oncology and pharmacology at Wayne State University School of Medicine (WSU SOM), also in Detroit. Additionally, he is vice president for medical affairs at Karmanos.

Dr Philip earned his medical degree at the University of Baghdad College of Medicine in Iraq. He earned his PhD in clinical pharmacology and pharmacogenetics at the University of London Guy’s Hospital Medical School in London, England. Dr Philip completed a residency at the University of Baghdad. He completed a fellowship in medical oncology at the University of Oxford in London, England, and at MD Anderson Cancer Center in Houston, Texas, United States. He is board certified in medical oncology in the United States and he is a fellow of the Royal College of Physicians in London. He joined Karmanos in 1995.

Dr Philip is a member of the Pancreatic Cancer Action Network’s Scientific Advisory Board. He also chairs the pancreatic cancer committee at the Southwest Oncology Group (SWOG) and is a member of the International Liver Cancer Association (ILCA) and the American Society of Clinical Oncology (ASCO). His major research interests are in the development of new therapies for gastrointestinal and neuroendocrine cancers with a special focus on pancreatic cancer. He has been the principal investigator on numerous clinical trials in gastrointestinal cancers.

A frequent national and international lecturer, Dr Philip has authored more than 200 manuscripts, review articles, and editorials, and has co-edited a book on pancreatic cancer. His lecture topics include pancreatic and biliary cancer, neuroendocrine tumors, and gastroesophageal cancer.

Education

Ph.D. Clinical Pharmacology and Pharmacogenetics, University of London Guy's Hospital Medical School, London, UK, 1986

Training

Education
(1986) Ph.D. Clinical Pharmacology and Pharmacogenetics, University of London Guy's Hospital Medical School, London, UK
(1977) M.D., University of Baghdad, College of Medicine, Baghdad, Iraq
(1971) Baccalaureate, American Jesuit Fathers College, Baghdad, Iraq

Postgraduate Training
(2013-2015) Fellowship in Leadership Course, Advisory Board Company, Washington DC
(1993-1995) Fellow in Medical Oncology, MD Anderson Cancer Center, Houston, Texas
(1988-1993) Senior Registrar in Medical Oncology, University of Oxford and Imperial Cancer Research Fund, Clinical Oncology Unit, Churchill Hospital, Oxford, United Kingdom
(1988) Registrar in Medical Oncology, Christie Hospital and Holt Radium Institute, Manchester, University of Manchester, United Kingdom
(1986-1988) Registrar in Medical Oncology, Charing Cross Hospital, University of London, London, United Kingdom
(1982-1986) Clinical Research Fellow and Honorary Registrar, Department of Clinical Pharmacology and Lymphoma Unit, Guy's Hospital Medical School, University of London, London, United Kingdom
(1981-1982) Resident Medical Officer, St. Raphael Hospital, Baghdad, Iraq
(1981-1982) Lecturer in Clinical Pharmacology, Baghdad University Medical College, Baghdad, Iraq
(1980-1981) Senior Resident in Internal Medicine, Medical City Teaching Hospital, University of Baghdad, Iraq
(1978-1980) Resident in Internal Medicine, Al-Taji Hospital, Baghdad, Iraq
(1977-1978) Intern in Internal Medicine and General Surgery, Medical City Teaching Hospital, University of Baghdad, Baghdad, Iraq

Fellowships

(2013-2015) Fellowship in Leadership Course, Advisory Board Company, Washington DC
(1993-1995) Fellow in Medical Oncology, MD Anderson Cancer Center, Houston, Texas

← Return to listing